CoChat

Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study

Open access
Long, Manhai, Ghisari, Mandana, Kjeldsen, Lisbeth, Wielsøe, Maria, Nørgaard-Pedersen, Bent, Mortensen, Erik Lykke, Abdallah, Morsi W., Bonefeld-Jørgensen, Eva C. · 2019 · Molecular Autism
Cited by 125

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Evidence has indicated that some non-inherited factors such as exposure to environmental pollutants are associated with neurodevelopment disorders like autism spectrum disorder (ASD). Studies report that endocrine disrupting compounds (EDCs), including polychlorinated biphenyls, organochlorine pesticides, perfluoroalkyl substances (PFAS), and some metals, have adverse effects on the fetal neurodevelopment. The aim of this study was to measure the amniotic fluid (AF) levels of EDCs and metals as well as the receptor transactivities induced by AF and investigate the possible link between prenatal exposure to EDCs and heavy metals and ASD risk. In this case-control study, we included AF samples of 75 ASD cases and 135 frequency-matched controls and measured the levels of the endogenous sex hormones, PFAS, and elements including heavy metals. The combined effect of endogenous hormones and EDCs on the receptor of estrogen (ER), androgen (AR), aryl hydrocarbon (AhR), and thyroid hormone-like activity were also determined and expressed as receptor ligand equivalents. We assessed the associations of AF levels of chemicals, sex hormones, and receptor activities with ASD risk using unconditional logistical regression analyses. To control for multiple comparisons, the false discovery rate (FDR) was used and q values less than 0.25 were designated as statistical significance. PFAS and metals were detectable in AF samples. The ASD cases had significantly lower AF levels of PFAS than controls, and the adjusted odds ratio (OR) was 0.410 (95% CI 0.174, 0.967; p = 0.042; FDR q value = 0.437) for perfluorooctane sulfonate (PFOS). The principal component, including PFAS congeners, copper, iron, and estrogenic activity, was significantly inversely associated with ASD risk (adjusted OR = 0.100; 95% CI 0.016, 0.630; p = 0.014; FDR q value = 0.098). Testosterone level in AF weakly associated with ASD risk (adjusted OR = 1.002; 95% CI 1.000, 1.004; p = 0.05). However, after multiple comparison correction, the association was not significant (FDR q value = 0.437). No significant associations between AF-induced receptor transactivities and ASD risk were observed. The adjusted OR was 2.176 (95%CI 0.115, 41.153) for the ratio of the combined androgenic activity to combined estrogenic activity. The presence of PFAS and heavy metals in AF indicates that they can cross the placenta. The inverse association between levels of PFAS congeners in AF and ASD risk might relate to the weak estrogenic activities and anti-androgenic activities of PFAS. The observed tendency of positive association between the ratio of combined androgenic effect to the combined estrogenic effect and ASD risk needs further studies to explore whether EDCs together with endogenous hormones play a role in the development of ASD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13229-018-0253-1

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 66

  1. APA. Autism spectrum disorder, 299.00 (F84.0). In: American Psychiatric Association diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013. · DOI · Paper page
  2. Parner ET, Schendel DE, Thorsen P. Autism prevalence trends over time in Denmark: changes in prevalence and age at diagnosis. Arch Pediatr Adolesc Med. 2008;162:1150–6. · DOI · Paper page
  3. Park HR, Lee JM, Moon HE, Lee DS, Kim BN, Kim J, Kim DG, Paek SH. A short review on the current understanding of autism spectrum disorders. Exp Neurobiol. 2016;25(1):13.
  4. Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G, Hallmayer JF. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry. 2004;61:618–27. · DOI · Paper page
  5. Knickmeyer R, Baron-Cohen S, Fane BA, Wheelwright S, Mathews GA, Conway GS, Brook CG, Hines M. Androgens and autistic traits: a study of individuals with congenital adrenal hyperplasia. Horm Behav. 2006;50:148–53. · DOI · Paper page
  6. Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry. 2012;17:389–401. · DOI · Paper page
  7. Costa LG, Aschner M, Vitalone A, Syversen T, Soldin OP. Developmental neuropathology of environmental agents. Annu Rev Pharmacol Toxicol. 2004;44:87–110. · DOI · Paper page
  8. Ek CJ, Dziegielewska KM, Habgood MD, Saunders NR. Barriers in the developing brain and Neurotoxicology. Neurotoxicology. 2012;33:586–604. · DOI · Paper page
  9. Bonefeld-Jorgensen EC. Biomonitoring in Greenland: human biomarkers of exposure and effects - a short review. Rural Remote Health. 2010;10:1362.
  10. Bonefeld-Jorgensen EC, Grunfeld HT, Gjermandsen IM. Effect of pesticides on estrogen receptor transactivation in vitro: a comparison of stable transfected MVLN and transient transfected MCF-7 cells. Mol Cell Endocrinol. 2005;244:20–30. · DOI
  11. Ghisari M, Bonefeld-Jorgensen EC. Impact of environmental chemicals on the thyroid hormone function in pituitary rat GH3 cells. Mol Cell Endocrinol. 2005;244:31–41. · DOI
  12. Long M, Laier P, Vinggaard AM, Andersen HR, Lynggaard J, Bonefeld-Jorgensen EC. Effects of currently used pesticides in the AhR-CALUX assay: comparison between the human TV101L and the rat H4IIE cell line. Toxicology. 2003;194:77–93. · DOI
  13. Kjeldsen LS, Bonefeld-Jorgensen EC. Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res Int. 2013;20:8031–44. · DOI · Paper page
  14. Bonefeld-Jorgensen EC, Long M, Hofmeister MV, Vinggaard AM. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environ Health Perspect. 2007;115(Suppl 1):69–76. · DOI · Paper page
  15. Ghisari M, Bonefeld-Jorgensen EC. Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions. Toxicol Lett. 2009;189:67–77. · DOI · Paper page
  16. Kruger T, Long M, Bonefeld-Jorgensen EC. Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor. Toxicology. 2008;246:112–23. · DOI · Paper page
  17. Braun JM. Endocrine disrupting compounds, gonadal hormones, and autism. Dev Med Child Neurol. 2012;54:1068. · DOI
  18. Fuentes S, Vicens P, Colomina MT, Domingo JL. Behavioral effects in adult mice exposed to perfluorooctane sulfonate (PFOS). Toxicology. 2007;242:123–9. · DOI
  19. Johansson N, Eriksson P, Viberg H. Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Toxicol Sci. 2009;108:412–8. · DOI · Paper page
  20. Kim SM, Han DH, Lyoo HS, Min KJ, Kim KH, Renshaw P. Exposure to environmental toxins in mothers of children with autism spectrum disorder. Psychiatry Investig. 2010;7:122–7. · DOI · Paper page
  21. Eskenazi B, Marks AR, Bradman A, Harley K, Barr DB, Johnson C, Morga N, Jewell NP. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ Health Perspect. 2007;115:792–8. · DOI · Paper page
  22. McCanlies EC, Fekedulegn D, Mnatsakanova A, Burchfiel CM, Sanderson WT, Charles LE, Hertz-Picciotto I. Parental occupational exposures and autism spectrum disorder. J Autism Dev Disord. 2012;42:2323–34. · DOI
  23. Beard J. Iron deficiency alters brain development and functioning. J Nutr. 2003;133:1468S–72S. · DOI · Paper page
  24. Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging. 2006;10:377–85.
  25. Kodama H, Fujisawa C, Bhadhprasit W. Pathology, clinical features and treatments of congenital copper metabolic disorders--focus on neurologic aspects. Brain and Development. 2011;33:243–51. · DOI
  26. Walter T. Effect of iron-deficiency anemia on cognitive skills and neuromaturation in infancy and childhood. Food Nutr Bull. 2003;24:S104–10. · DOI
  27. Bonefeld-Jorgensen EC, Ghisari M, Wielsoe M, Bjerregaard-Olesen C, Kjeldsen LS, Long M. Biomonitoring and hormone-disrupting effect biomarkers of persistent organic pollutants in vitro and ex vivo. Basic Clin Pharmacol Toxicol. 2014;115:118–28. · DOI
  28. Long M, Bonefeld-Jorgensen EC. Dioxin-like activity in environmental and human samples from Greenland and Denmark. Chemosphere. 2012;89:919–28. · DOI
  29. Beall MH, van den Wijngaard JP, van Gemert MJ, Ross MG. Regulation of amniotic fluid volume. Placenta. 2007;28:824–32. · DOI
  30. Lyall K, Schmidt RJ, Hertz-Picciotto I. Maternal lifestyle and environmental risk factors for autism spectrum disorders. Int J Epidemiol. 2014;43:443–64. · DOI · Paper page
  31. Abdallah MW, Larsen N, Grove J, Norgaard-Pedersen B, Thorsen P, Mortensen EL, Hougaard DM. Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort. Brain Behav Immun. 2012;26:170–6. · DOI
  32. Norgaard-Pedersen B, Hougaard DM. Storage policies and use of the Danish Newborn Screening Biobank. J Inherit Metab Dis. 2007;30:530–6. · DOI · Paper page
  33. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263–8.
  34. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull. 1998;45:320–3.
  35. Kugler KG, Hackl WO, Mueller LA, Fiegl H, Graber A, Pfeiffer RM. The impact of sample storage time on estimates of association in biomarker discovery studies. J Clin Bioinforma. 2011;1:9. · DOI · Paper page
  36. Lauritsen MB, Pedersen CB, Mortensen PB. The incidence and prevalence of pervasive developmental disorders: a Danish population-based study. Psychol Med. 2004;34:1339–46. · DOI · Paper page
  37. Bonefeld-Jorgensen EC, Long M, Bossi R, Ayotte P, Asmund G, Kruger T, Ghisari M, Mulvad G, Kern P, Nzulumiki P, Dewailly E. Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study. Environ Health. 2011;10:88. · DOI · Paper page
  38. Asmund G, Vorkamp K, Backus S, Comba M. An update on analytical methods, quality assurance and quality control used in the Greenland AMAP programme: 1999-2002. Sci Total Environ. 2004;331:233–45. · doi:10.1016/j.scitotenv.2004.03.031
  39. Lutchmaya S, Baron-Cohen S, Raggatt P, Knickmeyer R, Manning JT. 2nd to 4th digit ratios, fetal testosterone and estradiol. Early Hum Dev. 2004;77:23–8. · DOI · Paper page
  40. Elliott CT, Francis KS, Shortt HD, McCaughey WJ. Determination of the concentrations of the steroids estradiol, progesterone and testosterone in bovine sera: comparison of commercial dissociation enhanced lanthanide fluorescence immunoassay kits with conventional radio and enzyme immunoassays. Analyst. 1995;120:1827–30. · doi:10.1039/an9952001827
  41. Long M, Deutch B, Bonefeld-Jorgensen EC. AhR transcriptional activity in serum of Inuits across Greenlandic districts. Environ Health. 2007;6:32. · DOI
  42. Pang S, Levine LS, Chow D, Sagiani F, Saenger P, New MI. Dihydrotestosterone and its relationship to testosterone in infancy and childhood. J Clin Endocrinol Metab. 1979;48:821–6. · DOI
  43. Wilson EM, French FS. Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. J Biol Chem. 1976;251:5620–9. · DOI · Paper page
  44. Jensen MS, Norgaard-Pedersen B, Toft G, Hougaard DM, Bonde JP, Cohen A, Thulstrup AM, Ivell R, Anand-Ivell R, Lindh CH, Jonsson BA. Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: temporal trends and timing of amniocentesis in pregnancy. Environ Health Perspect. 2012;120:897–903. · DOI · Paper page
  45. James WH. A potential explanation of some established major risk factors for autism. Dev Med Child Neurol. 2012;54:301–5. · DOI
  46. Glickman ME, Rao SR, Schultz MR. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol. 2014;67:850–7. · DOI · Paper page
  47. Timonen-Soivio L, Vanhala R, Malm H, Leivonen S, Jokiranta E, Hinkka-Yli-Salomaki S, Gissler M, Brown AS, Sourander A. The association between congenital anomalies and autism spectrum disorders in a Finnish national birth cohort. Dev Med Child Neurol. 2015;57:75–80. · DOI
  48. Los CA. The prejudices of least squares, principal components and common factors schemes. Computers Math Applic. 1989;17:1269–83. · doi:10.1016/0898-1221(89)90095-3
  49. Liberda EN, Tsuji LJ, Martin ID, Cote S, Ayotte P, Dewailly E, Nieboer E. Plasma concentrations of persistent organic pollutants in the Cree of northern Quebec, Canada: results from the multi-community environment-and-health study. Sci Total Environ. 2014;470-471:818–28. · doi:10.1016/j.scitotenv.2013.10.048
  50. Newby PK, Tucker KL. Empirically derived eating patterns using factor or cluster analysis: a review. Nutr Rev. 2004;62:177–203. · DOI · Paper page
  51. Stein CR, Wolff MS, Calafat AM, Kato K, Engel SM. Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a pilot study. Reprod Toxicol. 2012;34:312–6. · DOI · Paper page
  52. Olsen GW, Mair DC, Reagen WK, Ellefson ME, Ehresman DJ, Butenhoff JL, Zobel LR. Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. Chemosphere. 2007;68:105–11. · DOI
  53. Bjerregaard-Olesen C, Bach CC, Long M, Ghisari M, Bossi R, Bech BH, Nohr EA, Henriksen TB, Olsen J, Bonefeld-Jorgensen EC. Time trends of perfluorinated alkyl acids in serum from Danish pregnant women 2008-2013. Environ Int. 2016;91:14–21. · DOI
  54. Vestergren R, Cousins IT. Tracking the pathways of human exposure to perfluorocarboxylates. Environ Sci Technol. 2009;43:5565–75. · DOI · Paper page
  55. Lehmler HJ. Synthesis of environmentally relevant fluorinated surfactants--a review. Chemosphere. 2005;58:1471–96. · DOI · Paper page
  56. Power MC, Webster TF, Baccarelli AA, Weisskopf MG. Cross-sectional association between polyfluoroalkyl chemicals and cognitive limitation in the National Health and Nutrition Examination Survey. Neuroepidemiology. 2013;40:125–32. · DOI · Paper page
  57. Stein CR, Savitz DA, Bellinger DC. Perfluorooctanoate and neuropsychological outcomes in children. Epidemiology. 2013;24:590–9. · DOI · Paper page
  58. Strom M, Hansen S, Olsen SF, Haug LS, Rantakokko P, Kiviranta H, Halldorsson TI. Persistent organic pollutants measured in maternal serum and offspring neurodevelopmental outcomes--a prospective study with long-term follow-up. Environ Int. 2014;68:41–8. · DOI
  59. Liew Z, Ritz B, von Ehrenstein OS, Bech BH, Nohr EA, Fei C, Bossi R, Henriksen TB, Bonefeld-Jorgensen EC, Olsen J. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort. Environ Health Perspect. 2015;123:367–73. · DOI · Paper page
  60. Bjerregaard-Olesen C, Ghisari M, Bonefeld-Jorgensen EC. Activation of the estrogen receptor by human serum extracts containing mixtures of perfluorinated alkyl acids from pregnant women. Environ Res. 2016;151:71–9. · DOI
  61. Winneke G, Kramer U. Neurobehavioral aspects of lead neurotoxicity in children. Cent Eur J Public Health. 1997;5:65–9.
  62. Zafeiriou DI, Ververi A, Vargiami E. Childhood autism and associated comorbidities. Brain and Development. 2007;29:257–72. · DOI · Paper page
  63. Buck Louis GM, Sundaram R, Schisterman EF, Sweeney AM, Lynch CD, Gore-Langton RE, Maisog J, Kim S, Chen Z, Barr DB. Persistent environmental pollutants and couple fecundity: the LIFE study. Environ Health Perspect. 2013;121:231–6. · DOI · Paper page
  64. Luo Z, Shi X, Hu Q, Zhao B, Huang M. Structural evidence of perfluorooctane sulfonate transport by human serum albumin. Chem Res Toxicol. 2012;25:990–2. · DOI · Paper page
  65. Lawler CP, Croen LA, Grether JK, Van de Water J. Identifying environmental contributions to autism: provocative clues and false leads. Ment Retard Dev Disabil Res Rev. 2004;10:292–302. · DOI · Paper page
  66. Herbert MR, Russo JP, Yang S, Roohi J, Blaxill M, Kahler SG, Cremer L, Hatchwell E. Autism and environmental genomics. Neurotoxicology. 2006;27:671–84. · DOI · Paper page

Cited by

See all 125

Metadata

Authors
Long, M., Ghisari, M., Kjeldsen, L., Wielsøe, M., Nørgaard-Pedersen, B., Mortensen, E. L., Abdallah, M. W., & Bonefeld-Jørgensen, E. C.
Venue
Molecular Autism
Published
2019-01-09
Volume
10
Issue
1
Pages
1-1
ISSN
2040-2392 (ISSN-L)
OpenAlex
W2916864041
Cited by
125
References
35
FWCI
6.44
Type
journal article
Language
en
Open access
gold
Licence
creativecommons.org/licenses/by/4.0/ (tdm)
Funders
  • Aarhus Universitet (4414-11405)
  • Statens Serum Institute (271-05-0523/09-060179)
  • Danish Research and Innovation Council (271-07-0385)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study. https://app.cochat.ai/papers/10.1186/s13229-018-0253-1
The paper
Long, M., Ghisari, M., Kjeldsen, L., Wielsøe, M., Nørgaard-Pedersen, B., Mortensen, E. L., Abdallah, M. W., & Bonefeld-Jørgensen, E. C. (2019). Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study. Molecular Autism. https://doi.org/10.1186/s13229-018-0253-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.